BR102019005743A2 - COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION AND THE PROCESS OF MANUFACTURING A COSMETIC COMPOSITION - Google Patents
COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION AND THE PROCESS OF MANUFACTURING A COSMETIC COMPOSITION Download PDFInfo
- Publication number
- BR102019005743A2 BR102019005743A2 BR102019005743-2A BR102019005743A BR102019005743A2 BR 102019005743 A2 BR102019005743 A2 BR 102019005743A2 BR 102019005743 A BR102019005743 A BR 102019005743A BR 102019005743 A2 BR102019005743 A2 BR 102019005743A2
- Authority
- BR
- Brazil
- Prior art keywords
- cosmetic composition
- fact
- ascorbic acid
- mixture
- vitamin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 85
- 239000002537 cosmetic Substances 0.000 title claims abstract description 57
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 4
- 230000008569 process Effects 0.000 title claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 95
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 23
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 23
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 21
- 239000004480 active ingredient Substances 0.000 claims abstract description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 12
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 12
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 12
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 8
- 229940042585 tocopherol acetate Drugs 0.000 claims abstract description 8
- 229940116857 solanum lycopersicum extract Drugs 0.000 claims abstract description 7
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 24
- 229930003268 Vitamin C Natural products 0.000 claims description 24
- 235000019154 vitamin C Nutrition 0.000 claims description 24
- 239000011718 vitamin C Substances 0.000 claims description 24
- 229920001296 polysiloxane Polymers 0.000 claims description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- 239000003974 emollient agent Substances 0.000 claims description 10
- 230000003078 antioxidant effect Effects 0.000 claims description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 9
- 239000002250 absorbent Substances 0.000 claims description 8
- 230000002745 absorbent Effects 0.000 claims description 8
- 229940008099 dimethicone Drugs 0.000 claims description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 239000003906 humectant Substances 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 150000002334 glycols Chemical class 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 238000000265 homogenisation Methods 0.000 claims description 2
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 2
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 10
- 230000037303 wrinkles Effects 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 102000016942 Elastin Human genes 0.000 description 5
- 108010014258 Elastin Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920002549 elastin Polymers 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 240000003768 Solanum lycopersicum Species 0.000 description 4
- 235000002560 Solanum lycopersicum Nutrition 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 3
- 206010047623 Vitamin C deficiency Diseases 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 229940072107 ascorbate Drugs 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 208000010233 scurvy Diseases 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 102000004079 Prolyl Hydroxylases Human genes 0.000 description 1
- 108010043005 Prolyl Hydroxylases Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- -1 free radical ascorbate Chemical class 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
composição cosmética, uso de uma composição cosmética e processo de fabricação de uma composição cosmética a presente invenção refere-se a uma composição cosmética que compreende uma mistura de ácido ascórbico micronizado, extrato de solanum lycopersicum, ácido hialurônico e acetato de tocoferol como ingrediente ativo e uma base anidra para estabilização dos ingredientes ativos.cosmetic composition, use of a cosmetic composition and manufacturing process of a cosmetic composition the present invention relates to a cosmetic composition comprising a mixture of micronized ascorbic acid, solanum lycopersicum extract, hyaluronic acid and tocopherol acetate as an active ingredient and an anhydrous base for stabilizing the active ingredients.
Description
[001]. A presente invenção refere-se a uma composição cosmética que compreende uma mistura de ácido ascórbico micronizado, extrato de Solanum Lycopersicum, ácido hialurônico e acetato de tocoferol como ingrediente ativo e uma base anidra para estabilização dos ingredientes ativos.[001]. The present invention relates to a cosmetic composition comprising a mixture of micronized ascorbic acid, extract of Solanum Lycopersicum, hyaluronic acid and tocopherol acetate as an active ingredient and an anhydrous base for stabilizing the active ingredients.
[002]. O acúmulo de processos oxidativos na pele, principalmente nas proteínas, ocasiona alteração dos componentes do tecido conectivo, como atenuação da atividade proliferativa dos fibroblastos, redução e desorganização nas fibras de colágeno e elastina, diminuição de ácido hialurônico. Fatores estes, são considerados responsáveis por mudanças morfológicas e mecânicas que resultam na formação de rugas finas, perda da elasticidade, ressecamento, perda de tônus e resistência cutânea. (PETROCCA, Serafina. Dieta para a juventude. São Paulo: Mediafashion, 2010.).[002]. The accumulation of oxidative processes in the skin, mainly in proteins, causes alteration of connective tissue components, such as attenuation of the proliferative activity of fibroblasts, reduction and disorganization in collagen and elastin fibers, decrease in hyaluronic acid. These factors are considered responsible for morphological and mechanical changes that result in the formation of fine wrinkles, loss of elasticity, dryness, loss of tone and skin resistance. (PETROCCA, Serafina. Diet for youth. São Paulo: Mediafashion, 2010.).
[003]. As rugas se classificam em grau I, II e III, seguindo a descrição de Lapiere e Pierrard. O grau I corresponde às rugas de expressão, sem alteração dermoepidérmica; o grau II refere-se a rugas finas ou com ondulações; e o grau III confere as rugas gravitacionais, com a presença de alteração gravitacional modificando a estrutura dermoepidérmica e musculares (KEDE MV,. Dermatologia Estética. São Paulo: Atheneu, 2004).[003]. Wrinkles are classified as grade I, II and III, following the description of Lapiere and Pierrard. Grade I corresponds to the expression wrinkles, without dermoepidermal alteration; grade II refers to fine or wavy wrinkles; and grade III confers gravitational wrinkles, with the presence of gravitational alteration modifying the dermoepidermal and muscular structure (KEDE MV ,. Dermatologia Estética. São Paulo: Atheneu, 2004).
[004]. As rugas finas são comuns em pessoas de pele clara e com pouco mais de 30 anos e estão diretamente relacionadas à perda de colágeno. Apesar de ser o tipo mais superficial, confere um aspecto quebradiço à cútis, que se agrava, principalmente, pela exposição diária aos raios solares.[004]. Fine wrinkles are common in fair-skinned people in their early 30s and are directly related to loss of collagen. Despite being the most superficial type, it gives a brittle appearance to the skin, which is aggravated mainly by daily exposure to the sun's rays.
[005]. A Vitamina C vem sendo muito utilizada na composição de cosméticos devido sua atividade antioxidante, que atua na prevenção e tratamento do fotoenvelhecimento, sua ação antioxidante estimula a redução dos danos causados pelos raios UV.[005]. Vitamin C has been widely used in the composition of cosmetics due to its antioxidant activity, which acts in the prevention and treatment of photoaging, its antioxidant action stimulates the reduction of damage caused by UV rays.
[006]. A vitamina C, também conhecida como ou ascorbato, é uma a-quetalactonaque existe como um ânion hidroxila monovalente hidrolítico. O acréscimo de um elétron ao ascorbato forma o radical livre ascorbato. Essa forma transitória é mais estável do que outros radicais livres e pode aceitar outros elétrons, tornando-a um eliminador efetivo de radicais livres e assim um grande antioxidante.[006]. Vitamin C, also known as or ascorbate, is an α-ketalactone that exists as a hydrolytic monovalent hydroxyl anion. The addition of an electron to the ascorbate forms the free radical ascorbate. This transient form is more stable than other free radicals and can accept other electrons, making it an effective scavenger of free radicals and thus a great antioxidant.
[007]. A vitamina C é essencial para a biossíntese do colágeno. O escorbuto é um cofator para a atividade enzimática da prolil-hidroxilase, uma enzima que hidroxiliza os resíduos do prolil em pró-colágeno, elastina e outras proteínas com domínios colagenosos antes da formação da tripla hélice. A deficiência de ácido ascórbico leva a um prejuízo na formação do colágeno, resultando em escorbuto.[007]. Vitamin C is essential for collagen biosynthesis. Scurvy is a cofactor for the enzymatic activity of prolyl hydroxylase, an enzyme that hydroxylizes prolyl residues into pro-collagen, elastin and other proteins with collagenous domains before the formation of the triple helix. Ascorbic acid deficiency leads to impairment in the formation of collagen, resulting in scurvy.
[008]. O ácido ascórbico também parece influir na biossíntese de elastina. Estudos in vitro sugerem que a biossíntese de elastina por fibroblastos pode ser inibida pelo ascorbato. Isso pode ser útil na redução do acúmulo de elastina que é característico da pele foto-envelhecida.[008]. Ascorbic acid also appears to influence elastin biosynthesis. In vitro studies suggest that elastin biosynthesis by fibroblasts can be inhibited by ascorbate. This can be useful in reducing the accumulation of elastin that is characteristic of photo-aged skin.
[009]. Segundo Baumann (Leslie. Dermatologia Cosmética- - Princípios e Prática. Rio de Janeiro: Revinter, 2004.), a maior parte dos dados disponíveis sobre os efeitos da vitamina C vem de estudos que examinam os efeitos da vitamina C oral ou a vitamina C aplicada em culturas de tecidos. Infelizmente, não existem estudos que demonstrem que a ingestão de vitamina C oral aumente os níveis de vitamina C na pele. Consequentemente, as preparações tópicas de vitamina C são populares e o uso de ácido ascórbico pode ser formulado em formas solúveis em água ou lipídios.[009]. According to Baumann (Leslie. Cosmetic Dermatology - Principles and Practice. Rio de Janeiro: Revinter, 2004.), most of the available data on the effects of vitamin C comes from studies examining the effects of oral vitamin C or vitamin C applied to tissue cultures. Unfortunately, there are no studies that show that taking oral vitamin C increases levels of vitamin C in the skin. Consequently, topical vitamin C preparations are popular and the use of ascorbic acid can be formulated in water-soluble or lipid forms.
[0010] . Infelizmente, muitas das preparações tópicas disponíveis não são capazes de penetrar no estrato córneo, e consequentemente, são inúteis.[0010]. Unfortunately, many of the topical preparations available are unable to penetrate the stratum corneum, and are therefore useless.
[0011]. Outro problema com o ácido ascórbico aplicado topicamente é a falta de estabilidade. Como a maioria das preparações de vitamina C tópica não vem em frascos à prova de ar e que protejam da radiação UV, a maioria das preparações pode estar inativas algumas horas após a abertura do frasco.[0011]. Another problem with topically applied ascorbic acid is the lack of stability. Since most topical vitamin C preparations do not come in air-proof bottles that protect against UV radiation, most preparations may be inactive within a few hours of opening the bottle.
[0012]. É de conhecimento do estado da técnica que o Solanum Lycopersicum é um ingrediente ativo usado em formulações tópicas para ajudar na elasticidade da pele rejuvenescendo-a além de evitar a formação de melanina, colaborando com a hidratação e estabilização do ácido ascórbico na composição.[0012]. It is known from the state of the art that Solanum Lycopersicum is an active ingredient used in topical formulations to help skin elasticity by rejuvenating it in addition to avoiding the formation of melanin, collaborating with the hydration and stabilization of ascorbic acid in the composition.
[0013]. O Documento GB2451224 depositado por Jones Frances Prenna (GB), descreve uma composição cosmética compreendendo uma pluralidade de ingredientes ativos incluindo: pelo menos um esfoliante; pelo menos um adstringente; pelo menos um antioxidante; e pelo menos um hidratante. O esfoliante podendo ser ácido salicílico e ácido glicólico, o adstringente podendo ser o extrato de Hamamelis virginian, o antioxidante podendo ser o extrato de crisântemo parthenium. Essa composição cosmética compreende ainda, vantajosamente, pelo menos um extrato vegetal, tal como o Solanum lycopersicum.[0013]. GB2451224 filed by Jones Frances Prenna (GB), describes a cosmetic composition comprising a plurality of active ingredients including: at least one scrub; at least one astringent; at least one antioxidant; and at least one moisturizer. The scrub may be salicylic acid and glycolic acid, the astringent may be the extract of Hamamelis virginian, the antioxidant may be the extract of chrysanthemum parthenium. This cosmetic composition also advantageously comprises at least one plant extract, such as Solanum lycopersicum.
[0014]. Atualmente, existem no mercado algumas formulas que têm a mesma finalidade que a invenção em questão.[0014]. Currently, there are some formulas on the market that have the same purpose as the invention in question.
[0015]. A Adcos® tem uma composição que compreende vitamina 20%, ácido ferúlico, vitamina E e carcinina. Essa fórmula também é anidra, mas composta por outros ingredientes, diferentes da presente invenção, além dos princípios ativos também não serem as mesmas.[0015]. Adcos® has a composition comprising vitamin 20%, ferulic acid, vitamin E and carcinin. This formula is also anhydrous, but composed of other ingredients, different from the present invention, in addition to the active ingredients not being the same.
[0016]. A Skinceuticals® tem um produto liquido que vem com aplicação em conta-gotas, cuja composição compreende vitamina C a 10% e ácido ferúlico. Por sua vez a Dermage® também tem vitamina C pura na apresentação de conta-gotas.[0016]. Skinceuticals® has a liquid product that comes with dropper application, whose composition comprises 10% vitamin C and ferulic acid. In turn, Dermage® also has pure vitamin C in the presentation of droppers.
[0017]. Johnson & Johnson® também possui um produto com vem em forma de Kit, sendo que a primeira embalagem compreende vitamina C e a segunda compreende a um hidratante. Uma vez que os princípios ativos estão em embalagens diferentes, a vitamina C se mantém estável. Para aplicar, basta misturar as quantidades iguais do hidratante e da vitamina C pura.[0017]. Johnson & Johnson® also has a product that comes in the form of a Kit, the first package comprising vitamin C and the second comprising a moisturizer. Since the active ingredients are in different packaging, vitamin C remains stable. To apply, just mix equal amounts of moisturizer and pure vitamin C.
[0018]. A presente invenção descreve uma composição cosmética com compreende uma mistura de ativos, proporcionando um efeito sensorial diferenciado que hidrata ao mesmo tempo que reduz a oleosidade por conter adsorventes capazes de capturar a oleosidade da pele.[0018]. The present invention describes a cosmetic composition with a mixture of actives, providing a differentiated sensory effect that moisturizes while reducing oiliness by containing adsorbents capable of capturing skin oiliness.
[0019]. A presente invenção compreende uma mistura de Vitamina C Pura (Ácido L-ascórbico) a 10%; com Vitamina C micronizada, além de ácido hialurônico de baixo peso molecular, Vitamina E e Topicaroteno. Essa presente composição cosmética possui um efeito sensorial leve e de rápida absorção deixando um toque aveludado. Além disso, a presente composição estabiliza a vitamina C de forma inovadora.[0019]. The present invention comprises a blend of Pure Vitamin C (10% L-ascorbic acid); with micronized Vitamin C, in addition to low molecular weight hyaluronic acid, Vitamin E and Topicarotene. This present cosmetic composition has a light sensory effect and quick absorption leaving a velvety touch. In addition, the present composition stabilizes vitamin C in an innovative way.
[0020]. A Vitamina C Pura estimula a produção de colágeno, diminui linhas finas, clareia manchas, além de ser um poderoso antioxidante.[0020]. Pure Vitamin C stimulates collagen production, reduces fine lines, lightens blemishes, and is a powerful antioxidant.
[0021]. O Ácido Hialurônico possui alto poder de hidratação é um impulsionador da pele e colabora na síntese de colágeno[0021]. Hyaluronic Acid has a high hydrating power and is a skin booster and contributes to collagen synthesis
[0022]. A Vitamina E é um excelente antioxidante e retarda os efeitos do envelhecimento.[0022]. Vitamin E is an excellent antioxidant and slows down the effects of aging.
[0023]. Por sua vez, o Topicaroteno é um carotenoide incolor, precursor do licopeno e auxilia na diminuição da peroxidação lipídica e radicais livres, além de estabilizar e potencializar a Vitamina C[0023]. In turn, Topicarotene is a colorless carotenoid, precursor of lycopene and helps to decrease lipid peroxidation and free radicals, in addition to stabilizing and enhancing Vitamin C
[0024]. Mais precisamente, a presente invenção refere-se a composições cosméticas útil para prevenir e reverter as linhas finas de expressão, compreendendo em sua composição (i) uma mistura de ácido ascórbico, extrato de Solanum Lycopersicum, ácido hialurônico e acetato de tocoferol como ingrediente ativo; e (ii) uma base anidra para estabilização dos ingredientes ativos, compreendendo emolientes, emulsionantes, absorventes e umectantes; a presente composição cosmética compreendendo ainda (iii) uma fragrância.[0024]. More precisely, the present invention relates to cosmetic compositions useful to prevent and reverse fine lines of expression, comprising in its composition (i) a mixture of ascorbic acid, extract of Solanum Lycopersicum, hyaluronic acid and tocopherol acetate as active ingredient ; and (ii) an anhydrous base for stabilizing the active ingredients, comprising emollients, emulsifiers, absorbents and humectants; the present cosmetic composition further comprising (iii) a fragrance.
[0025]. Todos os componentes presentes no agente objeto desse documento são cosméticos, sendo considerados seguros e com baixa toxicidade, não apresentando os efeitos adversos que as formulações medicamentosas apresentam.[0025]. All components present in the agent object of this document are cosmetic, being considered safe and with low toxicity, without presenting the adverse effects that the drug formulations present.
[0026]. A presente composição fornece uma composição cosmeticamente aceitável para auxiliar no tratamento de antibrilho; no controle da oleosidade; na melhora da elasticidade; na melhora da firmeza da pele; na melhora da textura da pele; no clareamento de manchas de envelhecimento e na melhora de rugas.[0026]. The present composition provides a cosmetically acceptable composition to assist in the treatment of anti-shine; in the control of oiliness; in improving elasticity; improving the firmness of the skin; improving skin texture; in the lightening of aging spots and in the improvement of wrinkles.
[0027]. O objetivo da presente invenção é prover uma fórmula cosmética que estabiliza o ácido ascórbico por um longo período de tempo sem que ocorra a oxidação do mesmo. Para tanto o ácido ascórbico é micronizado e dispersado em uma base anidra que compreende uma mistura emoliente que compreende silicones e glicóis, uma mistura emulsionante e uma mistura absorvente tornam o sensorial da fórmula mais agradável.[0027]. The purpose of the present invention is to provide a cosmetic formula that stabilizes ascorbic acid for a long period of time without oxidation occurring. For this purpose, ascorbic acid is micronized and dispersed in an anhydrous base that comprises an emollient mixture comprising silicones and glycols, an emulsifying mixture and an absorbent mixture make the sensory of the formula more pleasant.
[0028]. Mais particularmente, a presente invenção refere-se a uma composição cosmética útil para auxiliar no tratamento para prevenir e reverter as linhas finas de expressão contendo (i) uma mistura de ingredientes ativos contendo ácido ascórbico micronizado, extrato de Solanum Lycopersicum, ácido hialurônico e acetato de tocoferol; e (ii) uma base anidra para estabilização dos ingredientes ativos, compreendendo emolientes, emulsionantes, absorventes e umectantes; a presente composição cosmética compreendendo ainda (iii) uma fragrância livre de alérgenos.[0028]. More particularly, the present invention relates to a cosmetic composition useful to assist in the treatment to prevent and reverse fine expression lines containing (i) a mixture of active ingredients containing micronized ascorbic acid, Solanum Lycopersicum extract, hyaluronic acid and acetate tocopherol; and (ii) an anhydrous base for stabilizing the active ingredients, comprising emollients, emulsifiers, absorbents and humectants; the present cosmetic composition further comprising (iii) an allergen-free fragrance.
[0029]. A mistura de ingredientes ativos está presente na composição cosmética com 1% p.p. a 30% p.p. de ácido ascórbico micronizado, 0,1% p.p. a 5% p.p. de extrato de Solanum Lycopersicum, 0,05% p.p. a 2 % p.p. de ácido hialurônico e 0,1% p.p. a 2 % p.p. de acetato de tocoferol.[0029]. The mixture of active ingredients is present in the cosmetic composition with 1% pp to 30% pp of micronized ascorbic acid, 0.1% pp to 5% pp of Solanum Lycopersicum extract, 0.05% pp to 2% pp of hyaluronic acid and 0.1% pp to 2% pp of tocopherol acetate.
[0030]. Preferencialmente, os ingredientes ativos estão presentes na composição cosmética com 10% p.p. de ácido ascórbico micronizado, 0,1% p.p. de extrato de Solanum Lycopersicum, 0,1% p.p. de ácido hialurônico e 1% p.p de acetato de tocoferol. O ácido ascórbico ácido ascórbico está micronizado em um tamanho que varia entre 10 μm e 20 μm.[0030]. Preferably, the active ingredients are present in the cosmetic composition with 10% w / w micronized ascorbic acid, 0.1% w / w Solanum Lycopersicum extract, 0.1% w / w hyaluronic acid and 1% w / w tocopherol acetate. Ascorbic acid Ascorbic acid is micronized in a size ranging from 10 μm to 20 μm.
[0031]. Por sua vez, a base anidra representa 50% p.p a 90% p.p. da composição cosmética, em que a base anidra compreende 42,8% p.p. de uma mistura emoliente, 3,00% p.p. de uma mistura emulsionante, 4,00% p.p. de uma mistura absorvente, 37,94% p.p. de um umectante.[0031]. In turn, the anhydrous base represents 50% pp to 90% pp of the cosmetic composition, in which the anhydrous base comprises 42.8% pp of an emollient mixture, 3.00% pp of an emulsifying mixture, 4.00% pp of an absorbent mixture, 37.94% w / w of a humectant.
[0032]. A mistura emoliente compreende silicones e glicóis, tais como dimeticones e glicóis de diferentes pesos moleculares. Mais especificamente, a mistura emoliente compreende 0,2% p.p. de caprilil glicol, 0,1% p.p. de ácido caprilidroxamico, 0,1% p.p. de glicerina, 23,0% p.p. de ciclopentasiloxano, 10% p.p. de crospolímero de alquil C30-45 cetearil dimeticona, 2,4% p.p. de isononanoato de isononila, 0,5 % p.p. de crospolímero de dimeticona e 0,5 % p.p. de vinil dimeticona.[0032]. The emollient mixture comprises silicones and glycols, such as dimethicones and glycols of different molecular weights. More specifically, the emollient mixture comprises 0.2% pp of caprylyl glycol, 0.1% pp of caprylhydroxamic acid, 0.1% pp of glycerin, 23.0% pp of cyclopentasiloxane, 10% pp of C30- alkyl crospolimer 45 cetearyl dimethicone, 2.4% pp of isononyl isononanoate, 0.5% pp of crospolymer of dimethicone and 0.5% pp of vinyl dimethicone.
[0033]. O emulsionante compreende 3% p.p. de dimeticona PEG/PPG-20/15.[0033]. The emulsifier comprises 3% p.p. of dimethicone PEG / PPG-20/15.
[0034]. A mistura absorvente compreende 3% p.p. de crospolimero de metacrilato de metila e 1% p.p. de sílica.[0034]. The absorbent mixture comprises 3% w / w crospolimer of methyl methacrylate and 1% w / w silica.
[0035]. O umectante é selecionado entre o grupo de glicóis, preferencialmente o propilenoglicol.[0035]. The humectant is selected from the group of glycols, preferably propylene glycol.
[0036]. Adicionalmente a composição cosmética compreende ainda 0,06% p.p. de uma fragrância livre de alérgenos.[0036]. In addition, the cosmetic composition also comprises 0.06% p.p. of an allergen-free fragrance.
[0037]. A composição cosmética apresenta-se na forma de gel, creme gel, gel creme, emulgel, emulsão e sérum.[0037]. The cosmetic composition comes in the form of gel, cream gel, cream gel, emulgel, emulsion and serum.
[0038]. A composição cosmética descrita pela presente invenção é usada para fabricar um medicamento tópico antioxidante para a prevenção e tratamento das linhas finas de expressão.[0038]. The cosmetic composition described by the present invention is used to manufacture a topical antioxidant medication for the prevention and treatment of fine lines of expression.
[0039]. A presente invenção também descreve o processo de fabricação da composição cosmética em estudo.[0039]. The present invention also describes the process of making the cosmetic composition under study.
[0040]. O produto só será formado se houver alta força de cisalhamento entre a fase do silicone e a fase dos glicóis. Assim, o PROCESSO DE FABRICAÇÃO da COMPOSIÇÃO COSMÉTICA caracterizado por compreender as seguintes etapas:
- i. a Vitamina C é dispersada com alta rotação no glicol;
- ii. em um recipiente auxiliar, os silicones são homogeneizados;
- iii. posteriormente, a fase contendo ácido ascórbico e glicol é gotejada na fase dos silicones com alta homogeneização, com rotação de 15.000 rpm por minuto;
- iv. por fim, vagarosamente a fase contendo os silicones e o emulsionante vai sendo gotejada com velocidade não controlada, incorporando o glicol com a vitamina C.
- i. Vitamin C is dispersed with high rotation in glycol;
- ii. in an auxiliary container, the silicones are homogenized;
- iii. later, the phase containing ascorbic acid and glycol is dripped on the silicones phase with high homogenization, with a rotation of 15,000 rpm per minute;
- iv. finally, slowly the phase containing the silicones and the emulsifier is dripped with uncontrolled speed, incorporating the glycol with vitamin C.
[0041]. Importante enfatizar que a presente composição cosmética só fica estável ao seguir o processo de fabricação acima descrito.[0041]. It is important to emphasize that the present cosmetic composition is only stable when following the manufacturing process described above.
[0042]. Resultados de eficácia percebida em 28 dias:
TABELA - Avaliação de eficácia percebida pelos participantes da pesquisa
Questão % de aceitação
A Composição cosmética rem efeito antibrilho 92,3%
A Composição cosmética contra a oleosidade da pele 89,7%
A Composição cosmética tem efeito antienvelhecimento 82,1%
Composição cosmética melhora a elasticidade da pele 87,2%
A Composição cosmética melhora a firmeza da pele 94,9%
A Composição cosmética melhora a textura da pele 97,4%
A Composição cosmética promove o clareamento de manchas de envelhecimento 84,6%
A Composição cosmética melhora as rugas da pele 76,9%[0042]. Results of perceived efficacy in 28 days:
TABLE - Evaluation of effectiveness perceived by the research participants
% Acceptance Issue
Cosmetic composition with anti-shine effect 92.3%
Cosmetic Composition against skin oiliness 89.7%
Cosmetic composition has anti-aging effect 82.1%
Cosmetic composition improves skin elasticity 87.2%
Cosmetic composition improves skin firmness 94.9%
Cosmetic makeup improves skin texture 97.4%
Cosmetic composition promotes the lightening of aging spots 84.6%
Cosmetic composition improves skin wrinkles 76.9%
[0043]. Assim, pelas vantagens que oferece, e ainda, por revestir-se de características verdadeiramente inovadores que preenchem todos os requisitos de novidade e originalidade no gênero, a presente composição cosmética reúne melhorias dermatológicas funcionais quando comparado aos demais constantes do estado da técnica.[0043]. Thus, due to the advantages it offers, and also because it has truly innovative characteristics that fulfill all the requirements of novelty and originality in the genre, the present cosmetic composition brings together functional dermatological improvements when compared to the other constant in the state of the art.
Claims (15)
- i. a Vitamina C é dispersada com alta rotação no glicol;
- ii. em um recipiente auxiliar, os silicones são homogeneizados;
- iii. posteriormente, a fase contendo ácido ascórbico e glicol é gotejada na fase dos silicones com alta homogeneização, com rotação de 15.000 rpm por minuto;
- iv. por fim, vagarosamente a fase contendo os silicones e o emulsionante vai sendo gotejada com velocidade não controlada, incorporando o glicol com a vitamina C.
- i. Vitamin C is dispersed with high rotation in glycol;
- ii. in an auxiliary container, the silicones are homogenized;
- iii. later, the phase containing ascorbic acid and glycol is dripped on the silicones phase with high homogenization, with a rotation of 15,000 rpm per minute;
- iv. finally, slowly the phase containing the silicones and the emulsifier is dripped with uncontrolled speed, incorporating the glycol with vitamin C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR102019005743-2A BR102019005743B1 (en) | 2019-03-22 | COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION AND MANUFACTURING PROCESS OF A COSMETIC COMPOSITION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR102019005743-2A BR102019005743B1 (en) | 2019-03-22 | COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION AND MANUFACTURING PROCESS OF A COSMETIC COMPOSITION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR102019005743A2 true BR102019005743A2 (en) | 2020-09-29 |
| BR102019005743B1 BR102019005743B1 (en) | 2024-07-16 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9597279B2 (en) | Anti-aging dermal composition comprising herbal extracts | |
| CN111888284B (en) | Cosmetic composition | |
| US20180071205A1 (en) | Stable Vitamin C System | |
| RU2764769C2 (en) | Products for external application with a two-phase system | |
| EP3226976A1 (en) | Topical skin care composition comprising trifluoroacetyl tripeptide-2 | |
| ES2692188T3 (en) | Cosmetic composition for skin rejuvenation | |
| KR20140024877A (en) | Topical skin care formulations comprising plant extracts | |
| KR20070097092A (en) | Composition and method for treating hyperpigmented skin | |
| BRPI0619269A2 (en) | antibacterial composition for contact with mucosa or other oral cavity tissues, oral care composition, use of a scleroglucan, process for preparing a cosmetic or dermatological formulation, concentrate and method of reducing the number of bacteria and / or minimizing adhesion of bacteria in the oral mucosa | |
| EP2968107A1 (en) | Cosmetic compositions and uses thereof | |
| FR3059231A1 (en) | COMPOSITION COMPRISING A TRUFFLE EXTRACT AND A DIHYDROCHALCONE | |
| BRPI1010464A2 (en) | compositions comprising an nfkb inhibitor and a tropoelastine promoter | |
| EP2992934A1 (en) | A cosmetic composition and a process for preparing said composition | |
| FR2984742A1 (en) | USE OF STEVIOL, A GLYCOSIDE DERIVATIVE OF STEVIOL, OR ANY OF THEIR ISOMERS, FOR PREVENTING, REDUCING AND / OR TREATING AN ALTERATION OF SKIN PAINT. | |
| US9901533B2 (en) | Anti-aging formulation with stabilized Epigallo Catechin Gallate (ECGC) | |
| TW202203912A (en) | Non-aqueous topical formulations | |
| EP3478368B1 (en) | Composition for combating the signs of ageing of the skin and hair and nails | |
| JP2007210915A (en) | Skin preparation for external use | |
| JP2023513759A (en) | Deuterated polyunsaturated fatty acids or esters thereof for cosmetic applications | |
| BR112013024572B1 (en) | Cosmetic process and cosmetic use of at least one compound of formula (I) | |
| CN112294739A (en) | Multi-effect whitening composition and application thereof in moisturizer | |
| ES2791066T3 (en) | Composition to reduce skin aging disorders, comprising a retinaldehyde and an extract of leontopodium alpinum | |
| BR102019005743A2 (en) | COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION AND THE PROCESS OF MANUFACTURING A COSMETIC COMPOSITION | |
| BR102019005743B1 (en) | COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION AND MANUFACTURING PROCESS OF A COSMETIC COMPOSITION | |
| CN111840157A (en) | Camellia flower compound composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/03/2019, OBSERVADAS AS CONDICOES LEGAIS |